[ Price : $8.95]
The CDER Office of Therapeutic Biologics and Biosimilars recommends expiration dates for first interchangeable exclusivity for Boe...[ Price : $8.95]
FDA approves an Eli Lilly NDA for Zepbound (tirzepatide) subcutaneous injection for chronic weight management in obese adults who ...[ Price : $8.95]
CBER director Peter Marks and three medical center researchers editorialize on the value of registries to promote convalescent pla...[ Price : $8.95]
Organon says it agrees with an FDA policy change to have a biosimilar statement accompany both biosimilars and interchangeables.[ Price : $8.95]
Reps. Marie Gluesenkamp Perez (D-WA), Sean Casten (D-IL), and Gerry Connolly (D-VA) introduce a bill to ban brand companies from e...[ Price : $8.95]
Federal Register notice: FDA makes available a guidance entitled Real-Time Oncology Review (RTOR).[ Price : $8.95]
FDA approves a PMA for the Recor Medical Paradise renal denervation system to treat hypertension.[ Price : $8.95]
Becton Dickinsons CareFusion unit recalls its Alaris Patient Controlled Analgesia infusion pump module 8120 because the compatible...